Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

Forge Resources Intercepts 105 G/T Au in the Payoff Zone at Alotta Project, Yukon (click to learn more)

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare Biotechnology

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for infectious diseases and medical countermeasures. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro... see more

Add To Watchlist

Bullboard (CSE:RVV)

View:

(7)
•••

Comment by 90guppyon Jan 12, 2023 9:07am

RE:Revive Therapeutics Ltd. Closes $4.3 Million Offering

COOL aka da- FO-OL, just fcking call out mgt not to mess up the type c meet, that is all you have to do rather be a useless POS.

124

(27)
•••

Post by cool888on Jan 12, 2023 6:48am

Revive Therapeutics Ltd. Closes $4.3 Million Offering

#Bucillamine https://ca.finance.yahoo.com/news/revive-therapeutics-ltd-closes-4-110000951.html

185

Forge Resources Intercepts 105 G/T Au in the Payoff Zone at Alotta Project, Yukon

posted Nov 17, 2025 9:00am by Forge Resources Corp.

Forge Resources announces the first gold assay results from the Phase 2 diamond drill program at Alotta, intercepting 105 g/t Au over a core length of 1.25 m. Majority of assays results are still pending ...read more

(0)
•••

Post by PressReleaseon Jan 12, 2023 6:00am

New Press Release - Revive Therapeutics Ltd. Closes $4.3 Million Offering

TORONTO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- REVIVE THERAPEUTICS LTD. (CSE: RVV; OTCQB: RVVTF; FRANKFURT:31R) (“Revive” or the “Company”) is pleased to announce that it has completed the closing of its previously announced private placement (the “Offering”) by issuing a total of 28,676,064 units...read article.

(7)
•••

Comment by 90guppyon Jan 10, 2023 3:42pm

RE:$RVV -First-in-kind psychedelic trials treat opioid and meth

FO-OL- aka COOL call out RVV mgt to not fyck up the type c meet, this is all in the hands of mgt, everything hangs on them.

134

(145)
•••

Post by CrazyPropheton Jan 10, 2023 11:56am

Looks to be under

Accumulation

191

(27)
•••

Post by cool888on Jan 09, 2023 8:52pm

$RVV -First-in-kind psychedelic trials treat opioid and meth

#psychedelic https://news.wisc.edu/two-first-in-kind-clinical-trials-explore-psilocybin-for-substance-misuse/ Study sponsored by Revive. See “Funded Clinical Studies”. https://pharmacy.wisc ...more

323

(27)
•••

Post by cool888on Jan 09, 2023 3:53pm

Publication Showing Bucillamine’s Potential Impact on C-19 !

#Bucillamine https://ca.finance.yahoo.com/news/revive-therapeutics-announces-publication-showing-203400945.html

216

(0)
•••

Post by PressReleaseon Jan 09, 2023 3:35pm

New Press Release - Revive Therapeutics Announces Publication Showing Bucillamine's Potential Impact on COVID-19 Omicron Variants

TORONTO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announces an independent...read article.

(7)
•••

Comment by 90guppyon Jan 09, 2023 9:24am

RE:China - to include Paxlovid in state health insurance fail !

FO-OL, aka Cool, all you have to do is call out the mgt to make sure they dont blow the type c WRO. That is all rvv needs to do, be on top of the type c WRO requirement and dont mess up. This China ...more

165

(27)
•••

Post by cool888on Jan 08, 2023 6:39am